Dr. Shang is board certified in internal medicine, pediatrics, and addiction medicine. She practices combined adult and pediatric primary care in Turtle Creek in addition to integrated addiction medicine and primary care through the Internal Medicine Recovery Engagement Program (IM-REP). She also attends on the inpatient Substance Treatment and Recovery Services (STARS) at UPMC Presbyterian. Her additional clinical interests include expanding service and treatment capacity for adolescents and young adults who use substances.
As core faculty for the Med-Peds Residency and Addiction Medicine Fellowship, Dr. Shang is involved in resident and fellow education and precepting. She is also the director of the Adolescent and Young Adult Addiction Medicine Fellowship, funded through HRSA. She is the rotation director for the addiction medicine elective for residents and medical students and runs the Wilson Scholars in Addiction Medicine Research Award, an 8-week mentored research experience for medical students that includes a structured didactic curriculum on addiction medicine and basic research topics. Dr. Shang also teaches at the medical student level as a Clinical Skills Preceptor.
Dr. Shang's research interests include curricular evaluation, quality improvement, and program development centered on expanding access to substance use disorder treatment, increasing the addiction workforce capacity, and decreasing healthcare-associated stigma. She is also part of the Harm Reduction Research Collaborative, which focuses on increasing access to harm reduction, including integrating these services in clinical settings.
- BS, Biochemistry, University of Illinois at Chicago, 2014
- MD, University of Illinois at Chicago College of Medicine, 2018
- Internal Medicine-Pediatrics Residency, University of Pittsburgh Medical Center, 2022
- Addiction Medicine Fellowship, University of Pittsburgh Medical Center, 2023
- Medical Education Fellowship, University of Pittsburgh, 2024
- MS, Medical Education, University of Pittsburgh, 2024
Education & Training
Shang M, Thiel B, Liebschutz JM, Kraemer KL, Freund A, Jawa R. Implementing harm reduction kits in an office-based addiction treatment program. Harm Reduct J. 2023; 20(1):163.
Jawa R, Ismail S, Shang M, Murray S, Murray-Krezan C, Zheng Y, Mackin S, Washington K, Alvarez P, Dillon J, McMurtrie G, Stein M, Walley A, Liebschutz JM. Drug use practices an wound care experiences in the age of xylazine adulteration. Drug and Alcohol Dependence. 2024; 263:112390.
Hull I*, Jawa R*, Shang M, Davis C, McMurtrie G, King C, Krans E. Implications of xylazine exposure in pregnancy: A narrative review. Journal of Addictive Diseases. 2024; 1-8.
Shang M*, Hull I*, Liebschutz JM, et al. Building multidisciplinary consensus on inpatient xylazine management through clinical protocols. Subst Use Addct J. 2025.
- Alpha Omega Alpha Honor Medical Society, University of Illinois at Chicago College of Medicine, 2017
- General Academic Pediatrics Primary Care Award, Children's Hospital of Pittsburgh, 2022
- Presbyterian Innovation Grant Awardee, 2023
- PInCH (Pitt Innovation Challenge) Semi-Finalist, Clinical and Translational Science Institute, University of Pittsburgh, 2023
- Best Med Ed Project, Third Annual Den Hofkosh Pediatric Educators' Symposium, Department of Pediatrics, University of Pittsburgh, 2024
- Nomination, Quality and Practice Innovation Award, Society of General Internal Medicine, 2025
- Med-Peds Special Recognition Award, UPMC Internal Medicine-Pediatrics Residency, 2025